the Key Special Project of National Key R & D Program(2017YFA0105502);the 2020 Open Project of National Clinical Medicine Research Center for Hematological System Diseases(2020ZKZC02);the Special Project of Basic Frontier of Military Medicine(2018YQYLY002)
Weihao WANG, Shijie YANG, Yuxuan DU, et al. Establishment of a mouse model of skin-dominant chronic graft-versus-host disease[J]. Journal of Third Military Medical University, 2021, 43(21): 2286-2293.
DOI:
Weihao WANG, Shijie YANG, Yuxuan DU, et al. Establishment of a mouse model of skin-dominant chronic graft-versus-host disease[J]. Journal of Third Military Medical University, 2021, 43(21): 2286-2293. DOI: 10.16016/j.1000-5404.202108060.
Establishment of a mouse model of skin-dominant chronic graft-versus-host disease
To construct a mouse model of skin-dominant chronic graft-versus-host disease (cGVHD).
Methods
2
BALB/c mice were irradiated with lethal dose and then received a mixture of bone marrow and spleen cells transplantation from B10.D2 donor mice. Then the clinical manifestations
pathological features of the mice and cell subsets of targeted organs were observed to evaluate the establishment of model.
Results
2
The clinical manifestations of the model mice mainly involved skin depilation
sclerosis
dandruff
scab
as well as arched back and joint stiffness due to skin shrinkage and
sclerosis. The clinicopathological scores were increased with the progression of cGVHD
while the model mice showed no obvious manifestations of intestinal cGVHD. Moreover
increase of collagen deposition and decrease or even disappearance of hair follicles was observed on the histopathologic sections of skin
while other targeted organs showed no major alterations. T cell subsets analysis indicated that Th1 cells
CD4
+
IL-13
+
T cells and Tc1 cells were closely related to the disease progression.
Conclusion
2
The skin-dominant cGVHD mouse model is successfully established
with skin damage and fibrosis as main pathological changes.
关键词
Keywords
references
KRÖGER N. Preventing graft-versus-host disease without losing graft-versus-leukemia effect after allogeneic stem-cell transplantation[J]. J Clin Oncol, 2020, 38(29): 3357-3360. DOI: 10.1200/jco.20.01756.
Applied Hematopoietic Stem Cell Group of Hematology Branch of Chinese Medical Association, Hematological Diseases Transformation Committee of Chinese Anti-Cancer Society. Chinese expert consensus on diagnosis and treatment of chronic graft-versus-host disease (cGVHD) (2021 edition)[J]. Chin J Hematol, 2021, 42(4): 265-275.
CHEN T, LI X P, GAO Q G, et al . Different methods for detecting serum markers in patients with acute graft versus host disease[J ] . J Third Mil Med Univ, 2019, 41(23): 2280-2284. DOI: 10.16016/j.1000-5404.201907252.
HOGENES M C H, VAN DORP S, VAN KUIK J, et al . Modifying graft-versus-host disease in a humanized mouse model by targeting macrophages or B-cells[J ] . J Immunol Res, 2019, 2019: 3538963. DOI: 10.1155/2019/3538963.
YE Y, RICARD L, STOCKER N, et al . A novel mouse model of acute graft-versus-host disease based on chemotherapy conditioning and G-CSF mobilized graft[J ] . Bone Marrow Transplant, 2020, 55(3): 570-577. DOI: 10.1038/s41409-019-0700-4.
MVLLER A M S, MIN D, WERNIG G, et al . Modeling chronic graft-versus-host disease in MHC-matched mouse strains: genetics, graft composition, and tissue targets[J ] . Biol Blood Marrow Transplant, 2019, 25(12): 2338-2349. DOI: 10.1016/j.bbmt.2019.08.001.
SCHROEDER M A, DIPERSIO J F. Mouse models of graft-versus-host disease: advances and limitations[J]. Dis Model Mech, 2011, 4(3): 318-333. DOI: 10.1242/dmm.006668.
BOIERI M, SHAH P, JALAPOTHU D, et al . Rat acute GvHD is Th1 driven and characterized by predominant donor CD4 + T-cell infiltration of skin and gut[J ] . Exp Hematol, 2017, 50: 33-45. e3. DOI: 10.1016/j.exphem.2017.02.002..
MALARD F, BOSSARD C, ARBEZ J, et al . Plasmacytoid dendritic cells (PDC) and Th17 immune response contribution in gut acute graft-versus-host-disease (GVHD)[J ] . Blood, 2011, 118(21): 2968. DOI: 10.1182/blood.V118.21.2968.2968.
GUO L Y, LAI P L, WANG Y L, et al . Extracellular vesicles derived from mesenchymal stem cells prevent skin fibrosis in the cGVHD mouse model by suppressing the activation of macrophages and B cells immune response[J ] . Int Immunopharmacol, 2020, 84: 106541. DOI: 10.1016/j.intimp.2020.106541.
KAPLAN D H, ANDERSON B E, MCNIFF J M, et al . Target antigens determine graft-versus-host disease phenotype[J ] . J Immunol, 2004, 173(9): 5467-5475. DOI: 10.4049/jimmunol.173.9.5467.
PAN B, WANG D, LI L, et al . IL-22 accelerates Thymus regeneration via Stat3/mcl-1 and decreases chronic graft-versus-host disease in mice after allotransplants[J ] . Biol Blood Marrow Transplant, 2019, 25(10): 1911-1919. DOI: 10.1016/j.bbmt.2019.06.002.
FURUE K, ITO T, TSUJI G, et al . The IL-13-OVOL1-FLG axis in atopic dermatitis[J ] . Immunology, 2019, 158(4): 281-286. DOI: 10.1111/imm.13120.
BODOOR K, AL-QARQAZ F, HEIS L A, et al . IL-33/13 axis and IL-4/31 axis play distinct roles in inflammatory process and itch in psoriasis and atopic dermatitis[J ] . Clin Cosmet Investig Dermatol, 2020, 13: 419-424. DOI: 10.2147/ccid.s257647.
ODAK I, DEPKAT-JAKOB A, BECK M, et al . Donor-derived IL-17A and IL-17F deficiency triggers Th1 allo-responses and increases gut leakage during acute GVHD[J ] . PLoS ONE, 2020, 15(4): e0231222. DOI: 10.1371/journal.pone.0231222.
MORIN F, KAVIAN N, MARUT W, et al . Inhibition of EGFR tyrosine kinase by erlotinib prevents sclerodermatous graft-versus-host disease in a mouse model[J ] . J Invest Dermatol, 2015, 135(10): 2385-2393. DOI: 10.1038/jid.2015.174.
YEH S P, LIAO Y M, LO W J, et al . Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host disease[J ] . PLoS ONE, 2012, 7(9): e44416. DOI: 10.1371/journal.pone.0044416.
TAWARA I, NIEVES E, LIU C, et al . Host basophils are dispensable for induction of donor T helper 2 cell differentiation and severity of experimental graft-versus-host disease[J ] . Biol Blood Marrow Transplant, 2011, 17(12): 1747-1753. DOI: 10.1016/j.bbmt.2011.08.013.
LEE G R. The balance of Th17 versus treg cells in autoimmunity[J]. Int J Mol Sci, 2018, 19(3): 730. DOI: 10.3390/ijms19030730.
YASUDA K, TAKEUCHI Y, HIROTA K. The pathogenicity of Th17 cells in autoimmune diseases[J]. Semin Immunopathol, 2019, 41(3): 283-297. DOI: 10.1007/s00281-019-00733-8.
DELENS L, EHX G, SOMJA J, et al . In vitro Th17-polarized human CD4 + T cells exacerbate xenogeneic graft-versus-host disease[J ] . Biol Blood Marrow Transplant, 2019, 25(2): 204-215. DOI: 10.1016/j.bbmt.2018.10.007..
GUTIÉRREZ-HOYA A, LÓPEZ-SANTIAGO R, VELA-OJEDA J, et al . Role of CD8 regulatory T cells versus Tc1 and Tc17 cells in the development of human graft-versus-host disease[J ] . J Immunol Res, 2017, 2017: 1236219. DOI: 10.1155/2017/1236219.
CHASSET F, LE BUANEC H, SICRE DE FONTBRUNE F, et al . Evidence of Th1, Th17 and Tc17 cells in psoriasiform chronic graft-versus-host disease[J ] . Exp Dermatol, 2016, 25(1): 64-65. DOI:10.1111/exd.12857.
State Key Laboratory of Trauma, Burns and Combined Injury, Department of Anti-radiation Medicine, Chongqing Engineering Research Center for Nanomedicine, Institute of Combined Injury, Faculty of Preventive Military Medicine, Army Medical University (Third Military Medical University)
Neuroscience Center, Chongqing Medical University
Seven-year Training Group of Grade 2013, First Clinical College of Chongqing Medical University